AbbVie manage to keep Humira Bx of Amgen out of US market till 2023 !
As per information from various sources, AbbVie has signed a pact with Amgen which will ensure that Humira Bx will not be launched by Amgen in the US till 2023. However, Amgen can still launch the Humira Bx in the EU next year.